Perrigo Reports First Quarter 2021 Financial Results From Continuing Operations
Consumer Transformation Nearing Completion Ahead of Schedule
Rx Transaction On-Track to Close in Q3 21; Rx Segment Now Reported in Discontinued Operations
2021 Guidance Reaffirmed
Share this article
Share this article
DUBLIN, May 11, 2021 /PRNewswire/ Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Consumer Self-Care Products, today announced financial results from continuing operations for the first quarter of fiscal year 2021 ended April 3, 2021. The Consumer Self-Care Americas ( CSCA ) segment, the Consumer Self-Care International ( CSCI ) segment and Corporate are included in results from continuing operations. Financial results from the generic Rx pharmaceuticals business are reported as discontinued operations. All comparisons are against the prior-year fiscal first quarter, unless otherwise noted.